Mount Sinai Clinical Trials

The Mount Sinai Health System is a renowned academic medical center located in New York City, providing a wide range of medical services to patients from all over the world. One of the key areas of focus for the institution is its clinical trials program, which plays a crucial role in advancing medical research and improving patient care. Mount Sinai Clinical Trials are designed to evaluate the safety and efficacy of new treatments, medications, and medical devices, with the ultimate goal of developing innovative solutions for various diseases and conditions.

Overview of Mount Sinai Clinical Trials

Mount Sinai Clinical Trials are conducted by a team of experienced researchers, clinicians, and scientists who work together to design, implement, and analyze studies. The institution has a long history of conducting clinical trials, with a strong focus on translational research, which involves translating basic scientific discoveries into practical applications. The clinical trials program at Mount Sinai encompasses a broad range of therapeutic areas, including oncology, cardiology, neurology, and infectious diseases, among others.

Types of Clinical Trials at Mount Sinai

Mount Sinai offers various types of clinical trials, including:

• Phase I trials, which are the first stage of human clinical trials and focus on evaluating the safety and tolerability of a new treatment or medication
• Phase II trials, which assess the efficacy and side effects of a treatment or medication in a larger group of patients
• Phase III trials, which compare the efficacy and safety of a new treatment or medication with existing treatments or standard of care
• Phase IV trials, which are post-marketing studies that monitor the long-term safety and efficacy of a treatment or medication in a larger population

Additionally, Mount Sinai also conducts observational studies, which involve collecting data from patients who are receiving standard care, to better understand the natural history of a disease or condition.

Benefits of Participating in Mount Sinai Clinical Trials

Participating in clinical trials at Mount Sinai can provide patients with access to innovative treatments and medications that may not be available otherwise. Patients who participate in clinical trials also contribute to the advancement of medical research, which can lead to improved treatments and outcomes for future patients. Furthermore, clinical trials at Mount Sinai are conducted in a safe and controlled environment, with careful monitoring of patients’ health and well-being.

Current Clinical Trials at Mount Sinai

Mount Sinai is currently conducting a wide range of clinical trials, including studies on new treatments for cancer, cardiovascular disease, and neurological disorders. Some examples of current clinical trials include:

• A Phase III trial evaluating the efficacy and safety of a new immunotherapy for patients with advanced melanoma
• A Phase II trial assessing the efficacy and safety of a new medication for patients with heart failure
• A Phase I trial evaluating the safety and tolerability of a new gene therapy for patients with spinal muscular atrophy

Patients who are interested in participating in clinical trials at Mount Sinai can search for available studies on the institution’s website or contact the clinical trials office directly.

Eligibility and Enrollment

To participate in a clinical trial at Mount Sinai, patients must meet specific eligibility criteria, which vary depending on the study. Generally, patients must have a confirmed diagnosis of the condition being studied and must meet certain age, health, and other requirements. Patients who are interested in participating in a clinical trial should discuss their options with their healthcare provider, who can help determine whether they are eligible for a particular study.